We recently published a list of Jim Cramer Discusses These 12 Stocks & Trump DOJ’s Action Against Health Insurance Companies.

In a report released on February 26, John Ivankoe from J.P. Morgan maintained a Hold rating on Texas Roadhouse (TXRH – Research Report), with a ...

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Coupang (CPNG – Research Report), Texas Roadhouse ...

Texas Roadhouse Inc (NASDAQ:TXRH) is set to release its Q4 2024 earnings on Feb 20, 2025. The consensus estimate for Q4 2024 ...

We came across a bullish thesis on Texas Roadhouse, Inc. (TXRH) on Substack by Summit Stocks. In this article, we will ...

Texas Roadhouse shows strong profitability but faces flat margins and growth challenges. Read why I still see TXRH stock as a ...

Hernan E. Mujica, the CHIEF TECHNOLOGY OFFICER of $TXRH, sold 2,050 shares of the company on 02-24-2025 for an estimated $349,853. We received data on the trade from ...

Texas Roadhouse's Q4 results show impressive growth with a 23.5% YoY revenue increase and a 65.5% rise in income from ...

In this article, we are going to take a look at where Texas Roadhouse, Inc. (NASDAQ:TXRH) stands against other stocks that Jim Cramer Discusses with insights on Trump DOJ’s action against health ...

Texas Roadhouse (NASDAQ:TXRH – Free Report) had its target price trimmed by Stifel Nicolaus from $185.00 to $172.00 in a ...

Analysts have remained silent for TXRH’s upcoming release, with top and bottom line revisions remaining stagnant over recent months. Big growth is expected, with current estimates alluding to 53 ...